MAP1LC3A and gastric cancer: TEM, Western blot assay, and the mRFP-GFP-LC3 double fluorescence autophagy indicator system demonstrated that the miR-6788-5p inhibitor reduced the number of autophagosomes and autolysosomes, increased P62 expression, and decreased LC3 II expression in GC cells.